[go: up one dir, main page]

MX2009001200A - Uso antiviral de un tensoactivo cationico. - Google Patents

Uso antiviral de un tensoactivo cationico.

Info

Publication number
MX2009001200A
MX2009001200A MX2009001200A MX2009001200A MX2009001200A MX 2009001200 A MX2009001200 A MX 2009001200A MX 2009001200 A MX2009001200 A MX 2009001200A MX 2009001200 A MX2009001200 A MX 2009001200A MX 2009001200 A MX2009001200 A MX 2009001200A
Authority
MX
Mexico
Prior art keywords
virus
lae
cultures
cationic surfactants
type
Prior art date
Application number
MX2009001200A
Other languages
English (en)
Inventor
Bonvila Xavier Rocabayera
Roca Sergi Figueras
Pons Roger Segret
Original Assignee
Miret Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37728271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009001200(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Miret Lab filed Critical Miret Lab
Publication of MX2009001200A publication Critical patent/MX2009001200A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Los tensoactivos catiónicos derivados de la condensación de ácidos grasos y aminoácidos dibásicos eterificados, tal como el proveniente del ácido laúrico y la arginina, en particular el éster etílico de la lauramida del monohidrocloruro de la arginina (LAE), puede ser usado para la protección contra el crecimiento de microorganismos; los tensoactivos catiónicos de este tipo son también efectivos contra las infecciones virales; el añadido de LAE a cultivos de Herpes virus tipo 1, virus de Vaccinia y virus de la parainfluenza bovina 3 conduce a una reducción completa en una etapa temprana de los organismos virales en dichos cultivos, tales efectos comienzan a ser observados luego de 5 y 60 minutos.
MX2009001200A 2006-08-03 2006-08-03 Uso antiviral de un tensoactivo cationico. MX2009001200A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2006/065035 WO2008014824A1 (en) 2006-08-03 2006-08-03 Antiviral use of cationic surfactant

Publications (1)

Publication Number Publication Date
MX2009001200A true MX2009001200A (es) 2009-02-11

Family

ID=37728271

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009001200A MX2009001200A (es) 2006-08-03 2006-08-03 Uso antiviral de un tensoactivo cationico.

Country Status (13)

Country Link
EP (1) EP2046316B1 (es)
JP (1) JP2009545541A (es)
CN (1) CN101500552A (es)
AR (1) AR061309A1 (es)
AT (1) ATE482697T1 (es)
AU (1) AU2006346933A1 (es)
BR (1) BRPI0621922A2 (es)
CA (1) CA2658446A1 (es)
DE (1) DE602006017272D1 (es)
ES (1) ES2353726T3 (es)
IL (1) IL196583A0 (es)
MX (1) MX2009001200A (es)
WO (1) WO2008014824A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8193244B1 (en) 2008-05-29 2012-06-05 Nevada Naturals, Inc. Antimicrobial agents
US8926997B1 (en) 2003-02-06 2015-01-06 Richard F. Stockel Polymeric biocidal salts
US8795638B1 (en) 2003-08-26 2014-08-05 Nevada Naturals Inc. Compositions for dental care
US9023891B2 (en) 2008-05-29 2015-05-05 Nevada Naturals, Inc. Synergistic antimicrobial agents
BRPI0913835A2 (pt) 2008-07-02 2016-08-09 Miret Lab uso de tensoativos catiônicos como agentes esporicidas
CH701769A1 (de) 2009-09-08 2011-03-15 Schoeller Textil Ag Wiederbeladbare Ausrüstungen für Textilien und Formulierungen zur Beladung solcher Ausrüstungen.
EP2538790B1 (en) 2010-02-26 2015-07-29 Ajinomoto Co., Inc. Virus-inactivating composition containing low-molecular weight compound and arginine
US8834857B1 (en) 2011-01-18 2014-09-16 Nevada Naturals Inc. Deodorizing and skin cleaning
WO2013103556A1 (en) * 2012-01-05 2013-07-11 The Trustees Of Columbia University In The City Of New York Antimicrobial composition
WO2018004477A1 (en) * 2016-06-28 2018-01-04 Pisak Mehmet Nevzat Surfactants for treatment of skin infections caused by double stranded dna viruses of the herpesviridae or papillomaviridae families
CN108740356B (zh) * 2017-11-03 2022-10-25 华东师范大学 月桂酰精氨酸乙酯衍生物作为饲料添加剂的用途
CN108992437B (zh) * 2017-11-03 2021-10-12 华东师范大学 月桂酰精氨酸乙酯作为兽用抗菌剂的用途
CN108813166B (zh) * 2017-11-03 2022-06-07 华东师范大学 月桂酰精氨酸乙酯衍生物作为饲料营养能量物质的用途
CN110317684B (zh) * 2018-06-22 2021-05-25 华东师范大学 天然环保无毒的厨房油污清洗剂
CN110235899B (zh) * 2018-06-22 2022-04-05 华东师范大学 新的食品防腐剂及其制备方法和应用
CN110313487B (zh) * 2018-06-22 2021-07-27 华东师范大学 新型皮革防霉护理剂及其制备方法和应用
CN114869792A (zh) * 2018-06-22 2022-08-09 华东师范大学 新的口腔护理组合物及其制备方法和应用
CN110313488B (zh) * 2018-06-22 2021-07-27 华东师范大学 防霉型粘合剂及其制备方法和应用
CN112790196B (zh) * 2018-06-22 2022-05-06 华东师范大学 防腐杀菌型湿巾及其制备方法和应用
CN114869793A (zh) * 2018-06-22 2022-08-09 华东师范大学 新的洗浴用品组合物及其制备方法和应用
CN110302192A (zh) * 2018-06-22 2019-10-08 华东师范大学 新的抗微生物组合物及其制备方法和应用
CN112107566A (zh) * 2019-06-21 2020-12-22 华东师范大学 月桂酰精氨酸乙酯及其衍生物作为抗病毒剂的用途
US12186335B2 (en) 2020-04-23 2025-01-07 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant
KR20220054586A (ko) * 2020-08-31 2022-05-03 샐바시온 유에스에이 인크. 항바이러스 조성물
US12226731B2 (en) 2020-09-04 2025-02-18 G.H.L. International, Inc. Infectious agent air treatment system, apparatus, and method
WO2022122627A2 (en) 2020-12-08 2022-06-16 Laboratorios Miret, S.A. Cationic surfactants, in particular ethyl lauroyl arginate lae®, for treating or preventing infections and contaminations with coronavirus
CN114681628A (zh) * 2022-01-24 2022-07-01 抚顺东科新能源科技有限公司 一种温和无刺激医用超声凝胶及其制备方法
CN118459370A (zh) * 2023-02-08 2024-08-09 伍德沃德生物株式会社 盐类化合物及含有该盐类化合物的杀生物剂组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53118516A (en) * 1977-03-24 1978-10-17 Ajinomoto Co Inc Inactivation disinfectant of hepatitis-b virus
JPS5645402A (en) * 1979-09-21 1981-04-25 Ajinomoto Co Inc Disinfectant inactivating hepatitis virus b
US8388986B2 (en) * 2001-08-09 2013-03-05 Laboratorios Miret S.A. Use of cationic surfactants in cosmetic preparations
PT1437946E (pt) * 2001-10-25 2012-07-25 Miret Lab Utilização de um conservante catiónico em produtos alimentares
CA2467244C (en) * 2001-11-15 2011-01-04 Laboratorios Miret S.A. Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care
US20060264347A1 (en) * 2005-05-19 2006-11-23 Xintian Ming Antimicrobial composition

Also Published As

Publication number Publication date
EP2046316B1 (en) 2010-09-29
BRPI0621922A2 (pt) 2011-12-20
CN101500552A (zh) 2009-08-05
AU2006346933A1 (en) 2008-02-07
ES2353726T3 (es) 2011-03-04
JP2009545541A (ja) 2009-12-24
IL196583A0 (en) 2009-11-18
ATE482697T1 (de) 2010-10-15
DE602006017272D1 (de) 2010-11-11
WO2008014824A1 (en) 2008-02-07
EP2046316A1 (en) 2009-04-15
AR061309A1 (es) 2008-08-20
CA2658446A1 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
MX2009001200A (es) Uso antiviral de un tensoactivo cationico.
UY30485A1 (es) Uso antiviral de un tensioactivo cationico
WO2010051541A3 (en) Compositions containing delta-9-thc-amino acid esters and process of preparation
WO2010000744A3 (en) Use of cationic surfactants as sporicidal agents
BR0114147A (pt) Uso de tensoativos catiÈnicos em preparações cosméticas
IL213319A (en) Polylysis peptides for use in the treatment of bacterial infections
TNSN01108A1 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
BR0112420A (pt) Composto, composição farmacêutica, uso de um composto, e, método para produzir um efeito inibidor de ciclo celular (anti-proliferação celular) em um animal de sangue quente
MXPA05014082A (es) Acidos biariloximetilarenocarboxilicos.
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
NZ603232A (en) Nucleoside phosphoramidates
TW200724134A (en) Antimicrobial compositions and methods
TW200716589A (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole
WO2008068615A8 (en) Crystalline forms of ( 3 s ) -3- [n- (n' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluoro phenoxy) -4-0x0penta noic acid
WO2011133463A3 (en) Antimicrobial compositions comprising organic acid esters and methods for reducing virus and bacterial populations using such compositions
MX2011012334A (es) Composicion y metodo para promover el crecimiento de raices de plantas.
AR047513A1 (es) Metodos y composiciones para el tratamiento de cambios en la piel relacionados con el envejecimiento y los danos ocasionados por el medio ambiente
WO2008049920A3 (en) Il-21 variants
IL208697A0 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
MX2009012742A (es) Ingrediente activo novedoso en cicatrizacion y uso del mismo.
MY166631A (en) Orally administrable composition for improving skin quality
ES2422593T3 (es) Método y uso de una composición para lavavajillas
WO2012037498A3 (en) Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
WO2006125121A3 (en) Antimicrobial composition comprising a cationic surfacant and an iodinated sulpone compound
DK1296675T3 (da) Sammensætninger baseret på aminosyrer, egnet til behandling af hjertesvigt

Legal Events

Date Code Title Description
FG Grant or registration